Advertisement
Screener

P3 Health Partners Inc. (PIII) Cash and Cash Equivalents

2.8 / 5 stars · 68/120 Roast Me

P3 Health Partners Inc. Cash and Cash Equivalents

P3 Health Partners Inc. (PIII) had Cash and Cash Equivalents of $21.27 million as of 2026-06-30, per its 10-Q filed 2026-08-10.

Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments

us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-08-10

  • 2026-06-30: Cash and Cash Equivalents, at Carrying Value $21.27M.
  • 2026-03-31: Cash and Cash Equivalents, at Carrying Value $25.50M.
  • 2025-12-31: Cash and Cash Equivalents, at Carrying Value $25.01M.
  • 2025-09-30: Cash and Cash Equivalents, at Carrying Value $37.71M.
Period endCash and Cash Equivalents, at Carrying ValueCash and Cash Equivalents, at Carrying Value as first filed
2026-06-30$21.27M
10-Q · filed 2026-08-10
2026-03-31$25.50M
10-Q · filed 2026-05-14
2025-12-31$25.01M
10-Q · filed 2026-08-10
2025-09-30$37.71M
10-Q · filed 2025-11-14
2025-06-30$38.58M
10-Q · filed 2026-08-10
2025-03-31$40.08M
10-Q · filed 2026-05-14
2024-12-31$38.82M
10-K · filed 2026-03-26
2024-09-30$62.96M
10-Q · filed 2025-11-14
2024-06-30$73.09M
10-Q · filed 2024-08-07
2024-03-31$27.30M
10-Q · filed 2024-05-08
2023-12-31$36.32M
10-K · filed 2025-03-28
2023-09-30$52.56M
10-Q · filed 2023-11-08
2023-06-30$59.92M
10-Q · filed 2023-08-07
2023-03-31$7.18M
10-Q · filed 2023-05-10
2022-12-31$17.54M
10-K · filed 2024-03-28
2022-09-30$34.36M
10-Q · filed 2022-11-14
2022-06-30$63.15M
10-Q · filed 2022-10-21
2022-03-31$110.35M
10-Q · filed 2022-10-21
2021-12-31$140.48M
10-K · filed 2023-03-31
$140.48M
10-K · filed 2022-10-21
2021-12-02$100.94K
8-K · filed 2023-11-09
$5.30M
10-K · filed 2022-10-21
2021-09-30$4.34M
10-Q · filed 2022-11-14
$97.29K
10-Q · filed 2021-11-18
2021-06-30$16.32M
10-Q · filed 2022-10-21
$583.70K
10-Q · filed 2021-08-20
2021-03-31$22.34M
10-Q · filed 2022-10-21
$1.29M
10-Q · filed 2021-05-25
2020-12-31$179.51K
8-K · filed 2023-11-09
2019-12-31$32.59M
10-K · filed 2022-10-21